Skip to content

Current ratio at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
1.3×0.0×
Artivion logo
ArtivionAORT
3.9×-1.7×
AngioDynamics logo
AngioDynamicsANGO
2.4×+0.1×
AIR
AirSculpt Technologies, Inc.AIRS
0.7×+0.2×
PROCEPT BioRobotics Corporation logo
PROCEPT BioRobotics CorporationPRCT
6.7×-2.2×
AtriCure logo
AtriCureATRC
4.3×+0.2×

Other financials

Income statement

See full
Revenue$12.5M+32.4%
Gross profit$7.5M-19.2%
Operating income-$5.5M-349%
Net income-$2.1M+48.6%
EPS (diluted)-$0.19-533%

Balance sheet

See full
Cash & equivalents$31.1M+0.4%
Total debt$39.5M+1.4%
Total equity$12.8M+22.1%
Total assets$63.0M+4.8%

Cash flow

See full
Operating cash flow-$572.0K+18.5%
CapEx$60.0K+9.1%
Free cash flow-$632.0K+16.5%

Valuation

See full
Market cap$181.07M+114%
Enterprise value$189.4M+101%
P/S3.2×+1.4×

Profitability

See full
Gross margin61.9%-3.1pp
Operating margin-46%+9.9pp
Net margin-16.2%-6.2pp
FCF margin-16.1%-4.8pp

Returns & leverage

See full
Return on equity-77.8%-22.4pp
Debt / equity3.1×-0.6×

Where this comes from

Calculated from Apyx Medical Corporation’s reported figures.

Based on the most recent quarter.

The official record: Apyx Medical Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apyx Medical Corporation's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apyx Medical Corporation's current ratio?
Apyx Medical Corporation (APYX) reported current ratio of 5.8× in Q1 2026.
How has Apyx Medical Corporation's current ratio changed year-over-year?
Apyx Medical Corporation's current ratio increased by 6.4% year-over-year, from 5.5× to 5.8×.
What is the long-term trend for Apyx Medical Corporation's current ratio?
Over 5 years (2020 to 2025), Apyx Medical Corporation's current ratio has grown at a -7.1% compound annual growth rate (CAGR), from 7.2× to 5×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.